Lexitas Pharma Services Acquires Erie Retina Research, CASExERIE and Element Erie
May 20, 2026
Lexitas Pharma Services (a QHP Capital portfolio company) acquired Erie Retina Research, along with CASExERIE and the assets of Element Erie: Imaging & Reading Center, to expand its retina-focused clinical research platform. Erie Retina Research will operate as a wholly owned subsidiary of Lexitas, CASExERIE will continue to operate within Erie Retina Research, and Element Erie’s imaging/reading capabilities will be integrated into Lexitas’ trial services.
- Buyers
- Lexitas Pharma Services, QHP Capital
- Targets
- Erie Retina Research, CASExERIE, LLC, Element Erie: Imaging & Reading Center PLLC
- Platforms
- Lexitas Pharma Services
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.